KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
02.13.21 - Medical Device Manufacturers are Working with Regulators to Reduce EO emissions...more
02.03.21 - iFyber collaborates with Allergan in Aesthetic Surgery Journal evaluating antimicrobial solutions and biofilm-associated bacteria...more
01.28.21 - Rochal Industries and iFyber author Efficacy of Wound Cleansers on Wound-Specific Organisms Using In Vitro and Ex Vivo Biofilm Models...more
01.19.21 - QIAGEN Adopts GNS Healthcare's Gemini - The in silico Patient™ Across Multiple Cancers...more
11.12.20 - Novomer Rennovo Biodegradeable Polymer Explained in Context of Single-Use Packaging...more
KensaGroup, LLC
2415 N. Triphammer Road
Ithaca, NY 14850
phone: 1.607.227.8695
Fax: 1.607.257.1139